These two tumors had the combination of trisomy chromosome 7 and monosomy chromosome 10 along with genetic alterations typical of conventional IDH-wildtype glioblastoma (e.g., TERT promoter mutation, CDKN2A/B homozygous deletion, EGFR amplification). The gene discussed is CDKN2A; the disease is glioblastoma.